Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Cedar Pollinosis
Total 2 results
Astellas Pharma Inc
Immunomic Therapeutics, Inc.
Completed
A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy
Cedar Pollinosis
Japan
Prof. Todor Popov
Unknown
POLlinosis and Exhaled Breath Temperature (POLET)
Pollinosis
Bulgaria
Sponsors and Collaborators
Damagen Genetic Diagnostic Center
José Castro
Shanghai IxCell Biotechnology Co., LTD
MB Clinical Research, LLC
Junta de Andalucía - Consejería de Salud y Familias, Spain
Hospital Sirio-Libanes Ensino e Pesquina
Universität Tübingen
Bon Secours Pediatric Dental Associates
Belfast Arthroplasty Research Trust (BART)
Mexican Emerging Infectious Diseases Clinical Research Network
GTEI
Department of Cardiology, Lausanne University Center Hospital, Lausanne, Switzerland
Narhalsan primary care rehabilitation
Don Cockcroft
University of Valladolid
Biotics, Inc.
Fabian Rohner
Crowley Carter Foundation
Plymouth University Peninsula Schools of Medicine & Dentistry (PUPSMD)
Castleton University
View Full List
Medical Conditions
Stage V Wilms Tumor
Infarction, Myocardial
Cryptococcosis or Aspergillosis Infections
Cystic Fibrosis in Adults, Chronic Colonization With Pseudomonas Aeruginosa
Congenital Nephrogenic Diabetes Insipidus
Syndrome Heart Disease
Gallbladder and Bile Duct Calculi
Residual Curarization
Milk Expression, Breast
Vesicoureteral Reflux (VUR)
Adolescent Oncology Patients
Nasotracheal Intubation
Chronic Arthritis, Longer Than Six Weeks Duration
Lung Cancer Non Small Cell
PSA Level Greater Than or Equal to 0.5
Refractory Childhood Epilepsy
Health Services, Geriatric
Support Groups
Vascular Aging
Lenses
View Full List
Drug Interventions
Sulfasalazine
Fluorescein + ALA
Dapagliflozin
ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
Lidocaine, epinephrine (Local anesthetic)
Granulocyte colony-stimulating factor (G-CSF)
PEP005 Gel
Axitinib plus toripalimab
SNAC
ABT-199
Quadratus Lumborum Block type 2
Azacitidine
PF-05212384
Gliadel Wafer
Fluorouracil
Etanercept
Metoprolol succinate sustained-release tablet
Cabozantinib
Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginase
Trimetazidine 35 mg
View Full List
CROs by country
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Costa Rica
Contract Research Organizations in Lithuania
Contract Research Organizations in Luxembourg
Contract Research Organizations in Malaysia
Contract Research Organizations in Mauritius
Contract Research Organizations in Nigeria
Contract Research Organizations in Panama
Contract Research Organizations in Philippines
Contract Research Organizations in Rwanda
Contract Research Organizations in Ukraine
Contract Research Organizations in United Arab Emirates
Contract Research Organizations in Zambia
CRO list by country
CROs in Colombia
Syneos Health
IQVIA
PPD
PRA Health Sciences
SGS
Coltrials SAS
PSI
Fortrea
NAMSA
CLINERGY Health Research
All CROs in Colombia
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe